This inventor holds 1 USPTO granted patent. Top assignees: Leland Stanford Junior University, University of Illinois. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,509 
1 out of 2,424 
Years Active: 2014
Title: Innovations of Hong-Hsing Liu in Liver Toxicity Reduction
Introduction
Hong-Hsing Liu is a notable inventor based in Santa Clara, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in reducing the risk of liver toxicity induced by agents such as acetaminophen. His work is crucial for developing safer medication protocols.
Latest Patents
Hong-Hsing Liu holds a patent titled "Compositions and methods for reducing the risk of agent-induced liver toxicity." This patent focuses on pharmaceutical compositions that include acetaminophen and components like S-adenosylhomocysteine (SAH) and S-methylmethionine (SMM). The methods described in the patent aim to reduce acetaminophen-induced liver toxicity in subjects by administering these components alongside acetaminophen.
Career Highlights
Throughout his career, Hong-Hsing Liu has worked with prestigious institutions such as the University of Illinois and Leland Stanford Junior University. His research has been instrumental in advancing the understanding of liver toxicity and developing effective treatments.
Collaborations
Some of his notable coworkers include Gary A Peltz and Guochun Liao. Their collaborative efforts have contributed to the success of his research and innovations.
Conclusion
Hong-Hsing Liu's work in reducing liver toxicity through innovative pharmaceutical compositions highlights his significant impact on medical science. His contributions are vital for improving patient safety and treatment efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile